Is there public reimbursement for weight loss medication?
No, there is no public reimbursement in Denmark for weight loss medication such as Wegovy, Mounjaro and Saxenda when it is used for weight loss.
The Danish Medicines Agency states that there is no public reimbursement for weight loss medication in Denmark, so you pay the full pharmacy price yourself. Novo Nordisk has applied twice for conditional general reimbursement (reimbursement that only applies to certain patient groups) for Wegovy and was refused on 1 July 2022 and 10 July 2025. In 2022 the Danish Medicines Agency judged that the price was not in reasonable proportion to the value of the treatment, and for the 2025 application, which covered a narrow group of young people aged 12 to 18, the Danish Medicines Agency called the treatment price very high.[1][2][3]
Saxenda was likewise refused general reimbursement in 2020. Medicine without reimbursement does not count towards your balance in the Central Reimbursement Register (CTR, which only records purchases of medicine eligible for reimbursement), so buying weight loss medication does not move you any closer to the high reimbursement rates.[4][5]
| Who | Do they reimburse weight loss medication? |
|---|---|
| The public sector | No. Wegovy was refused in 2022 and 2025, Saxenda in 2020 |
| Individual reimbursement via the doctor | Only time-limited, for selected patients with a serious and life-threatening weight-related condition |
| Sygeforsikringen "danmark" | No, unless the doctor has been granted individual reimbursement |
| Health insurance | We know of none that pays for the medicine. Some cover the doctor consultation |
| Employer | Novo Nordisk refunds its own employees, and the amount is taxed |
| The hospital | The regions are planning trials for well-defined groups, with no start date |
Each row is explained, with a source, in the sections of this post.[1]
Why does Ozempic have reimbursement when Wegovy does not?
Ozempic only has conditional reimbursement for certain patients with type 2 diabetes, while Wegovy for weight loss has no public reimbursement.
Ozempic contains the same active substance as Wegovy (semaglutide), but it is approved for type 2 diabetes and has conditional reimbursement for certain patients with type 2 diabetes. The Ozempic 2 mg strength has had conditional reimbursement since 9 November 2026 after a confidential price negotiation. The doctor may only tick the reimbursement box on the prescription when the patient belongs to the target group described in the clause, so the reimbursement does not apply when the purpose is weight loss.[6][1]
Can you get individual reimbursement for Wegovy or other weight loss medication?
The Danish Medicines Agency only grants individual reimbursement for Wegovy in rare cases, if you have a serious and life-threatening weight-related condition.
Only the doctor can apply to the Danish Medicines Agency for individual reimbursement (reimbursement the doctor applies for on behalf of one specific patient), and your finances are not part of the assessment. The Danish Medicines Agency only grants time-limited individual reimbursement for Wegovy to selected patients, including children and young people, who have a serious and life-threatening weight-related condition. A consultant at Hvidovre Hospital says in Ugeskrift for Læger (the Danish Medical Journal) that the reimbursement is only given for a limited period of, for example, six months, and that you then have to apply again.[7][8][9]
As a rule, the Danish Medicines Agency replies within 14 days, and some doctors charge a fee for applying. If you are granted individual reimbursement, the medicine becomes eligible for reimbursement for you, and your purchases then count towards your CTR balance.[7]
Does Sygeforsikringen "danmark" reimburse weight loss medication?
No, Sygeforsikringen "danmark" only reimburses weight loss medication if your doctor has been granted individual reimbursement by the Danish Medicines Agency.
According to the association's rules for 2026, Sygeforsikringen "danmark" does not give reimbursement for medicine that is wholly or partly aimed at weight loss and has no public reimbursement. The rule has applied since 1 January 2024, when Sygeforsikringen "danmark" removed reimbursement for weight loss medication, regardless of the product, because of a dramatic rise in costs. If you have been granted individual reimbursement, the medicine is no longer without public reimbursement, and you can ask Sygeforsikringen "danmark" about your cover.[10][11]
Does your health insurance or employer reimburse weight loss medication?
We know of no Danish health insurance that pays for the weight loss medication itself, and Novo Nordisk is the only employer we have found that has confirmed it covers Wegovy for employees.
At Recepta we know of no Danish health insurance, whether private or through work, that pays for the weight loss medication itself. Some health insurance policies cover the doctor consultation, but the terms vary, so ask your insurer and check your policy. Nor have we found any Danish employers other than Novo Nordisk that have publicly stated that they pay for weight loss medication for their staff, so ask your HR department if you are unsure.
Novo Nordisk pays for medicine the company itself makes, including Wegovy, for its employees in Denmark and their spouses on presentation of a pharmacy receipt. The scheme was confirmed to DR in November 2023 and described as being in force in Kristeligt Dagblad on 31 March 2025, and we have not found a more recent confirmation. According to the accountancy firm BDO, the employees are taxed on the refunded amount, which is in line with the main rule of the Danish Tax Agency (Skattestyrelsen) that employer-paid health services are taxable.[12][13][14][15]
Is reimbursement for weight loss medication on the way?
No, nothing has been decided on reimbursement for weight loss medication, although negotiations are under way and trials are being planned for small, well-defined groups with obesity.
In May 2025 the Danish Health Act was amended with a trial scheme with confidential prices. According to Ugeskrift for Læger (23 April 2026), this has paved the way for negotiations between Novo Nordisk and the regions' procurement organisation Amgros on an agreement that could potentially give reimbursement to a very narrow target group with obesity, but no result has been published. The government platform from June 2026 mentions a pilot scheme for people with obesity as a possibility, with no date, criteria or money set aside.[9][16]
In the agreement on the regions' finances for 2027 (June 2026), the regions will start trials in which medicine for obesity can be dispensed free of charge as part of hospital treatment for well-defined groups. The examples are young people with obesity caused by antipsychotic medication, women with obesity before fertility treatment, and patients for whom, after an individual assessment, the medicine is crucial for survival and physical function. Neither of these changes anything at the pharmacy today. 279,284 Danes have used Wegovy since its launch in December 2022.[17][9]
What can you do when there is no reimbursement for weight loss medication?
You can ask for the cheapest parallel-imported pack at the pharmacy and let the doctor assess whether individual reimbursement can be applied for.
The pharmacy price is the same at all Danish pharmacies and online pharmacies, it changes every 14 days, and today's prices are on Recepta's page Medication prices in Denmark. Parallel-imported packs (original medicine imported from another country) of the same medicine can be cheaper, so ask the pharmacy for the cheapest pack. In the price period 9 to 22 November 2026, for example, Wegovy 2.4 mg costs DKK 2,296.55 for 4 weeks in the manufacturer's pack and DKK 1,950.85 in the cheapest parallel-imported pack.[18]
At Recepta the doctor consultation is free, and membership costs DKK 0 for the first 4 weeks and then from DKK 138 per 4 weeks. You buy the medicine yourself at the pharmacy, and the doctor can assess whether you belong to the small group for whom it makes sense to apply for individual reimbursement.
Read also: Weight loss medication: types, effect, price and who can get it · Wegovy or Mounjaro: which is better? · Medication prices in Denmark
Questions and answers about reimbursement for weight loss medication
Can you get reimbursement for Mounjaro?
Does Wegovy count towards your medicine reimbursement (CTR)?
Do you have to pay tax if your employer pays for the weight loss medication?
Who can apply for individual reimbursement?
Sources
- Danish Medicines Agency (Lægemiddelstyrelsen): Spørgsmål og svar om slankemedicin og diabetesmedicin. Updated 31 March 2025. laegemiddelstyrelsen.dk
- Danish Medicines Agency: Decision on conditional general reimbursement for Wegovy, 1 July 2022. laegemiddelstyrelsen.dk
- Danish Medicines Agency: Wegovy får ikke generelt klausuleret tilskud. Decision, 10 July 2025. laegemiddelstyrelsen.dk
- Danish Medicines Agency: Decisions on general reimbursement (overview). laegemiddelstyrelsen.dk
- Danish Medicines Agency: Det Centrale Tilskudsregister (CTR). laegemiddelstyrelsen.dk
- Danish Medicines Agency: Ozempic 2 mg får generelt klausuleret tilskud efter fortrolig prisforhandling. News, 5 November 2026. laegemiddelstyrelsen.dk
- Danish Medicines Agency: Enkelttilskud. laegemiddelstyrelsen.dk
- Reimbursement Committee (Medicintilskudsnævnet): Recommendation to the Danish Medicines Agency on reimbursement for Wegovy, 26 May 2025. laegemiddelstyrelsen.dk
- Jessen B. Læger efterlyser hjælp til behandling af overvægtige. Ugeskrift for Læger, 23 April 2026. ugeskriftet.dk
- Sygeforsikringen "danmark": Medicin (2026), conditions for reimbursement. sygeforsikring.dk
- Sygeforsikringen "danmark": Nyt om tilskud til vægttabsmedicin. Members' magazine d-nyt no. 2, May 2023, page 5. sygeforsikring.dk
- Holm C. Novo Nordisk betaler det voldsomt populære slankemiddel Wegovy for ansatte og ægtefæller. DR Nyheder, 14 November 2023. dr.dk
- Winther TM. Wegovy populært i Kalundborg: Frynsegode på Novo får flere til at bruge vægttabsmidlet. Kristeligt Dagblad, 31 March 2025. kristeligt-dagblad.dk
- BDO: Article in Depechen on the taxation of Novo employees' refunds for Wegovy, 22 November 2023. bdo.dk
- Danish Tax Agency (Skattestyrelsen): Sundhedsydelser, skattepligtige og skattefri. skat.dk
- The Danish Government (Regeringen): Det politiske grundlag for firkløverregeringen. June 2026. regeringen.dk
- The Danish Government and Danish Regions (Danske Regioner): Aftale om regionernes økonomi for 2027. June 2026. regioner.dk
- Recepta: Medication prices in Denmark (the Danish price list, the price period 9 to 22 November 2026). recepta.dk